Kamani Oil first Indian edible oil firm to get FDA licence

Image
Press Trust of India Mumbai
Last Updated : Sep 03 2015 | 9:02 PM IST
Kamani Oil Industries today said it has become the first Indian edible oil firm to get Food and Drug Administration (FDA) licence for manufacturing pharmaceutical grade oils and fats.
"We are the first Indian vegetable oil company to get a FDA drug licence for manufacture of pharmaceutical grade oils and fats (IP/BP/USP/NF). This certification will assure our customers about the integrity of our manufacturing process as well as our compliance with the stringent FDA regulations," Kamani Oil Director Prakash Chawla told reporters here.
Under this segment, the company has the capacity to produce 100 tonne per month at its Khopoli plant near Mumbai. The manufacturing facility at Khopoli now meets with the requirements of Schedule M of Drugs and Cosmetics Act, 1940.
The overall pharmaceutical grade oils and fats market size is about 1,500 tonne a year.
"Earlier, the pharmaceutical companies used to import the oils and fats. Now they will have an option in the country itself," Chawla said, adding the technology used for this segment has been developed in house by the company.
The company produces a range of culinary oils like rice bran, sunflower, groundnut, coconut and supplies bulk edible oils to bakery, nutrition, confectionery industries as well.
"With this foray we are not expecting any major jump in our topline. However, we will be the pioneer in this segment by being the only one to get the FDA approval. Looking at the growth chart, overall, including our consumer and institutional business, we are expecting 20 per cent increase in revenue in the next three years," Chawla said.
Looking at the growth the company is also expanding its overall capacity at its Khopoli plant to 800 tonne per day from the current 500 tonne in the next one year and has invested Rs 50 crore for this purpose.
About expansion beyond Maharashtra, Chawla said the state itself has a lot of growth opportunity and so for the time being the company would like to further strengthen its presence here.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 03 2015 | 9:02 PM IST

Next Story